MHRA approves first medicine for rare immune disease APDS

The Medicines and Healthcare products Regulatory Agency (MHRA) has on 25 September approved leniolisib phosphate (Joenja) to treat a rare immune disease known as activated phosphoinositide 3-kinase delta syndrome or APDS in…

Read the original advice at Foreign Travel Advice (UK)